Marketisation


Around 20% of all NHS expenditure now goes to non-NHS bodies to provide care. Thousands of contracts exists between the NHS and these providers in addition to the contacts which underpin the NHS internal market.
CHPI has worked to examine the operation of this market and assess whether it delivers high quality care for patients and an efficient use of scarce resources.

This analysis looks at the evidence showing that creating and maintaining markets in the NHS has incurred huge financial costs and significant ‘opportunity costs’ – money which could have spent upon patient care and clinical redesign. The analysis goes on to argue that it is possible for the NHS to offer patient choice and high-quality health-care without the market.

Read More